# SLU-PP-332 Side Effects: What Studies and Users Report

Source: https://pepvault.app/peptides/slu-pp-332/side-effects

Last updated: 2026-10-06

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [SLU-PP-332](https://pepvault.app/peptides/slu-pp-332) Side effects

Peptide questions · SLU-PP-332

# SLU-PP-332 side effects: what studies and users report

Reviewed October 2026 Evidence: Emerging [Published by PepVault](https://pepvault.app/guides/how-we-research)

The library lists two common side effects for SLU-PP-332, no human safety data and unknown long-term effects, and a safety note; its research is mostly in animals and cells, so reports in people come from community use.

Its safety note opens: There is no human safety data: SLU-PP-332 has never been given to people in a published study, so its effects in people, short or long term, are unknown.

## What is commonly reported with SLU-PP-332

- No human safety data
- Unknown long-term effects

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other metabolic & GLP-1 compounds the library lists it for

| Effect | Also listed for (of 24) |
| --- | --- |
| No human safety data | None: listed for SLU-PP-332 alone |
| Unknown long-term effects | None: listed for SLU-PP-332 alone |

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track SLU-PP-332 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Which SLU-PP-332 side effects the metabolic & GLP-1 group shares

Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). None of SLU-PP-332’s 2 listed effects appears for another metabolic & GLP-1 compound: no human safety data and unknown long-term effects are its own in the library.

## More on SLU-PP-332

### SLU-PP-332

- [SLU-PP-332: the full reference](https://pepvault.app/peptides/slu-pp-332)
- [SLU-PP-332 dose guide](https://pepvault.app/lab/dosage/slu-pp-332)

### Studies

- [SLU-PP-332 cut fat mass and improved insulin sensitivity in obese mice](https://pepvault.app/research/slu-pp-332-billon-2024)
- [SLU-PP-332 improved ejection fraction and survival in mice](https://pepvault.app/research/slu-pp-332-xu-2024)
- [SLU-PP-332 increased exercise endurance in mice](https://pepvault.app/research/slu-pp-332-billon-2023)
- [All 4 studies](https://pepvault.app/research#slu-pp-332)

### Compared with

- [MOTS-c vs SLU-PP-332](https://pepvault.app/peptides/compare/mots-c-vs-slu-pp-332)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### SLU-PP-332 questions

- [SLU-PP-332: how long it takes to work](https://pepvault.app/peptides/slu-pp-332/how-long-to-work)
- [SLU-PP-332: what it’s stacked with](https://pepvault.app/peptides/slu-pp-332/stacks)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Purity](https://pepvault.app/glossary/purity)
- [S0 (non-approved substances)](https://pepvault.app/glossary/s0-non-approved-substances)

## What the SLU-PP-332 safety notes say

> The library’s safety note
>
> There is no human safety data: SLU-PP-332 has never been given to people in a published study, so its effects in people, short or long term, are unknown. In mice, 10 days at 50 mg/kg twice daily by injection caused no overt toxicity, with normal blood counts, electrolytes and muscle enzymes. It is sold as a research chemical, so purity, dose and contents aren't regulated, and anti-doping labs are building tests for it: as a compound with no approval for human use, it falls under the World Anti-Doping Agency's ban on non-approved substances (S0), in force at all times. Discuss with your clinician.

> The library’s interaction note
>
> No interaction data exist. In human liver enzyme preparations it is broken down into many metabolites (doping-control studies), but which enzymes do it, and what that means alongside other medicines, hasn't been studied. Running it with other metabolic compounds (GLP-1 drugs, MOTS-c, 5-Amino-1MQ) is untested. Discuss all your medicines with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

## Where the SLU-PP-332 reports come from

The library rates the evidence on SLU-PP-332 as emerging: mostly preclinical, with limited human data.

Of the library’s 5 research notes on SLU-PP-332, 4 rest on animal studies and 1 on community reports.

Our 4 study pages on SLU-PP-332: 4 animal studies (mice).

So the effects listed for SLU-PP-332 come from people who have used it, not from a controlled trial in people.

## Questions people ask

### What are the side effects of SLU-PP-332?

The library lists two common side effects for SLU-PP-332, no human safety data and unknown long-term effects, and a safety note; its research is mostly in animals and cells, so reports in people come from community use.

### Do SLU-PP-332’s side effects come from human studies?

The library rates the evidence on SLU-PP-332 as emerging, and its research is mostly in animals and cells, so reports in people come from community use.

### Which SLU-PP-332 side effects are its own?

Among the metabolic & GLP-1 compounds, the library lists no human safety data and unknown long-term effects for SLU-PP-332 alone.

### Does SLU-PP-332 interact with other medicines?

The library’s interaction note on SLU-PP-332 begins: No interaction data exist.

## More on SLU-PP-332

- [SLU-PP-332: the full library page](https://pepvault.app/peptides/slu-pp-332)
- [SLU-PP-332 dose guide](https://pepvault.app/lab/dosage/slu-pp-332)
- [SLU-PP-332: how long it takes to work](https://pepvault.app/peptides/slu-pp-332/how-long-to-work)
- [SLU-PP-332: what it’s stacked with](https://pepvault.app/peptides/slu-pp-332/stacks)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track SLU-PP-332 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track SLU-PP-332 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on SLU-PP-332

### SLU-PP-332

- [SLU-PP-332: the full reference](https://pepvault.app/peptides/slu-pp-332)
- [SLU-PP-332 dose guide](https://pepvault.app/lab/dosage/slu-pp-332)

### Studies

- [SLU-PP-332 cut fat mass and improved insulin sensitivity in obese mice](https://pepvault.app/research/slu-pp-332-billon-2024)
- [SLU-PP-332 improved ejection fraction and survival in mice](https://pepvault.app/research/slu-pp-332-xu-2024)
- [SLU-PP-332 increased exercise endurance in mice](https://pepvault.app/research/slu-pp-332-billon-2023)
- [All 4 studies](https://pepvault.app/research#slu-pp-332)

### Compared with

- [MOTS-c vs SLU-PP-332](https://pepvault.app/peptides/compare/mots-c-vs-slu-pp-332)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### SLU-PP-332 questions

- [SLU-PP-332: how long it takes to work](https://pepvault.app/peptides/slu-pp-332/how-long-to-work)
- [SLU-PP-332: what it’s stacked with](https://pepvault.app/peptides/slu-pp-332/stacks)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Purity](https://pepvault.app/glossary/purity)
- [S0 (non-approved substances)](https://pepvault.app/glossary/s0-non-approved-substances)

<!--promo-->

PepVault for iPhone

## Track SLU-PP-332 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## SLU-PP-332

- [SLU-PP-332 in the library](https://pepvault.app/peptides/slu-pp-332)
- [SLU-PP-332: how long it takes to work](https://pepvault.app/peptides/slu-pp-332/how-long-to-work)
- [SLU-PP-332: what it’s stacked with](https://pepvault.app/peptides/slu-pp-332/stacks)

## Tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The peptide glossary](https://pepvault.app/glossary)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
